Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea
· Delayed Price · Currency is KRW 9,600.00
-1,380.00 (-12.57%)
At close: Dec 5, 2025
Pharos iBio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -9,823 | -10,560 | -8,858 | -17,062 | -31,471 | -13,398 | Upgrade
|
| Depreciation & Amortization | 832.97 | 802.91 | 684.91 | 578.1 | 350.09 | 155.37 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 37.27 | 41.7 | -24.43 | -3.2 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | 27.15 | Upgrade
|
| Stock-Based Compensation | 604.67 | 484.25 | 533.61 | 618.15 | 386.27 | 168.3 | Upgrade
|
| Other Operating Activities | -273.92 | -43.04 | 15.56 | 7,683 | 24,007 | 7,672 | Upgrade
|
| Change in Accounts Receivable | - | - | - | - | - | 17.41 | Upgrade
|
| Change in Other Net Operating Assets | 384.78 | -48.55 | 169.48 | 22.76 | -588.38 | 71.5 | Upgrade
|
| Operating Cash Flow | -8,274 | -9,327 | -7,413 | -8,184 | -7,319 | -5,287 | Upgrade
|
| Capital Expenditures | -336.54 | -676.78 | -839.64 | -328.28 | -1,170 | -264.38 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 4 | 46.32 | 14.55 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -368.94 | -341.44 | -15.1 | -5.8 | -310.81 | -21.18 | Upgrade
|
| Investment in Securities | 9,084 | 590.7 | 1,368 | -6,267 | - | -3,926 | Upgrade
|
| Other Investing Activities | 1.63 | 19.83 | -43.18 | -11.92 | -91.25 | -6.5 | Upgrade
|
| Investing Cash Flow | 8,380 | -407.69 | 474.34 | -6,567 | -1,557 | -4,218 | Upgrade
|
| Long-Term Debt Repaid | - | -163.6 | -267.2 | -271.11 | -383.72 | -131.58 | Upgrade
|
| Net Debt Issued (Repaid) | -158.34 | -163.6 | -267.2 | -271.11 | -383.72 | -131.58 | Upgrade
|
| Issuance of Common Stock | 132.12 | 132.12 | 19,073 | - | - | 41.03 | Upgrade
|
| Other Financing Activities | 33.33 | - | -0 | - | -2 | 2 | Upgrade
|
| Financing Cash Flow | 7.11 | -31.48 | 18,805 | -271.11 | 17,635 | 15,906 | Upgrade
|
| Foreign Exchange Rate Adjustments | 640.11 | 538.18 | -90.8 | 21.67 | 246.65 | -195.92 | Upgrade
|
| Net Cash Flow | 753.03 | -9,228 | 11,776 | -15,000 | 9,005 | 6,205 | Upgrade
|
| Free Cash Flow | -8,611 | -10,004 | -8,253 | -8,512 | -8,489 | -5,551 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -2837.42% | -14892.94% | -2957.82% | Upgrade
|
| Free Cash Flow Per Share | -665.54 | -774.15 | -681.98 | -958.46 | -1462.70 | -981.82 | Upgrade
|
| Cash Interest Paid | - | - | 6.69 | 16.94 | 17.68 | 22.15 | Upgrade
|
| Cash Income Tax Paid | - | 19.49 | 74.11 | 10.01 | 6.62 | -0.36 | Upgrade
|
| Levered Free Cash Flow | -6,663 | -8,142 | -6,202 | -50,167 | 14,875 | 2,769 | Upgrade
|
| Unlevered Free Cash Flow | -6,658 | -8,139 | -6,195 | -48,153 | 18,946 | 5,443 | Upgrade
|
| Change in Working Capital | 384.78 | -48.55 | 169.48 | 22.76 | -588.38 | 88.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.